MC10 gets its first FDA clearance for BioStamp nPoint, a sensor platform for clinical trials

Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system. BioStamp nPoint is a more advanced version of the company's non-FDA cleared BioStampRC.

from MobiHealthNews https://ift.tt/2rNVnhf